XETRA •
Healthcare •
Drug Manufacturers - General •
Quote as of 08/03/2026 17:35
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization47,205 mln
Float982 mln
Earnings Date08/04/2026
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.78
Likely reliable
1-Year Forecast
54.92
Attractive
Relative Strength
31
/ 100
Underperforming
Debt / Equity
1.26
Elevated leverage
Pre-Tax Margin
16%
Healthy margin
Business Description
Founded in 1863 and headquartered in Leverkusen, Germany, Bayer is a global life sciences company serving customers across Europe, North America, Asia Pacific, Latin America, and beyond. Its healthcare business spans prescription medicines for heart conditions, women's health, cancer, and eye disease, alongside everyday over-the-counter products such as pain relievers, allergy treatments, and nutritional supplements. Through its agriculture division, Bayer supplies farmers with crop protection products, seeds, and digital tools designed to improve yields and manage pests and weeds. The company sells through pharmacies, supermarkets, hospitals, and online retailers, as well as directly to those working in farming.
